Benjamin Edwards Inc. Makes New Investment in iShares Biotechnology ETF (NASDAQ:IBB)

Benjamin Edwards Inc. bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the third quarter, HoldingsChannel.com reports. The fund bought 1,679 shares of the financial services provider’s stock, valued at approximately $244,000.

Several other institutional investors also recently made changes to their positions in IBB. BNP Paribas Financial Markets increased its holdings in shares of iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after acquiring an additional 538,899 shares during the period. Commerce Bank raised its holdings in shares of iShares Biotechnology ETF by 1.8% during the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock valued at $108,234,000 after buying an additional 12,921 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares during the last quarter. Main Management ETF Advisors LLC grew its holdings in iShares Biotechnology ETF by 2.6% in the 2nd quarter. Main Management ETF Advisors LLC now owns 578,835 shares of the financial services provider’s stock worth $79,451,000 after buying an additional 14,535 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. grew its holdings in iShares Biotechnology ETF by 24.6% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock worth $29,792,000 after buying an additional 42,822 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.8 %

Shares of iShares Biotechnology ETF stock opened at $140.56 on Wednesday. iShares Biotechnology ETF has a 1-year low of $123.56 and a 1-year high of $150.57. The business’s fifty day moving average price is $142.18 and its two-hundred day moving average price is $142.29.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.